IBDEI0J0 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8837,0)
 ;;=H40.022^^41^469^83
 ;;^UTILITY(U,$J,358.3,8837,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8837,1,3,0)
 ;;=3^Open-Angle w/ Borderline Findings,Hi Risk,Left Eye
 ;;^UTILITY(U,$J,358.3,8837,1,4,0)
 ;;=4^H40.022
 ;;^UTILITY(U,$J,358.3,8837,2)
 ;;=^5005729
 ;;^UTILITY(U,$J,358.3,8838,0)
 ;;=H40.031^^41^469^3
 ;;^UTILITY(U,$J,358.3,8838,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8838,1,3,0)
 ;;=3^Anatomical Narrow Angle,Right Eye
 ;;^UTILITY(U,$J,358.3,8838,1,4,0)
 ;;=4^H40.031
 ;;^UTILITY(U,$J,358.3,8838,2)
 ;;=^5005732
 ;;^UTILITY(U,$J,358.3,8839,0)
 ;;=H40.032^^41^469^2
 ;;^UTILITY(U,$J,358.3,8839,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8839,1,3,0)
 ;;=3^Anatomical Narrow Angle,Left Eye
 ;;^UTILITY(U,$J,358.3,8839,1,4,0)
 ;;=4^H40.032
 ;;^UTILITY(U,$J,358.3,8839,2)
 ;;=^5005733
 ;;^UTILITY(U,$J,358.3,8840,0)
 ;;=H40.033^^41^469^1
 ;;^UTILITY(U,$J,358.3,8840,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8840,1,3,0)
 ;;=3^Anatomical Narrow Angle,Bilateral
 ;;^UTILITY(U,$J,358.3,8840,1,4,0)
 ;;=4^H40.033
 ;;^UTILITY(U,$J,358.3,8840,2)
 ;;=^5005734
 ;;^UTILITY(U,$J,358.3,8841,0)
 ;;=H40.041^^41^469^123
 ;;^UTILITY(U,$J,358.3,8841,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8841,1,3,0)
 ;;=3^Steroid Responder,Right Eye
 ;;^UTILITY(U,$J,358.3,8841,1,4,0)
 ;;=4^H40.041
 ;;^UTILITY(U,$J,358.3,8841,2)
 ;;=^5005736
 ;;^UTILITY(U,$J,358.3,8842,0)
 ;;=H40.042^^41^469^122
 ;;^UTILITY(U,$J,358.3,8842,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8842,1,3,0)
 ;;=3^Steroid Responder,Left Eye
 ;;^UTILITY(U,$J,358.3,8842,1,4,0)
 ;;=4^H40.042
 ;;^UTILITY(U,$J,358.3,8842,2)
 ;;=^5005737
 ;;^UTILITY(U,$J,358.3,8843,0)
 ;;=H40.051^^41^469^76
 ;;^UTILITY(U,$J,358.3,8843,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8843,1,3,0)
 ;;=3^Ocular Hypertension,Right Eye
 ;;^UTILITY(U,$J,358.3,8843,1,4,0)
 ;;=4^H40.051
 ;;^UTILITY(U,$J,358.3,8843,2)
 ;;=^5005740
 ;;^UTILITY(U,$J,358.3,8844,0)
 ;;=H40.052^^41^469^75
 ;;^UTILITY(U,$J,358.3,8844,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8844,1,3,0)
 ;;=3^Ocular Hypertension,Left Eye
 ;;^UTILITY(U,$J,358.3,8844,1,4,0)
 ;;=4^H40.052
 ;;^UTILITY(U,$J,358.3,8844,2)
 ;;=^5005741
 ;;^UTILITY(U,$J,358.3,8845,0)
 ;;=H40.053^^41^469^74
 ;;^UTILITY(U,$J,358.3,8845,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8845,1,3,0)
 ;;=3^Ocular Hypertension,Bilateral
 ;;^UTILITY(U,$J,358.3,8845,1,4,0)
 ;;=4^H40.053
 ;;^UTILITY(U,$J,358.3,8845,2)
 ;;=^5005742
 ;;^UTILITY(U,$J,358.3,8846,0)
 ;;=H40.061^^41^469^106
 ;;^UTILITY(U,$J,358.3,8846,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8846,1,3,0)
 ;;=3^Primary Angle-Closure w/o Glaucoma Damage,Right Eye
 ;;^UTILITY(U,$J,358.3,8846,1,4,0)
 ;;=4^H40.061
 ;;^UTILITY(U,$J,358.3,8846,2)
 ;;=^5005744
 ;;^UTILITY(U,$J,358.3,8847,0)
 ;;=H40.062^^41^469^107
 ;;^UTILITY(U,$J,358.3,8847,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8847,1,3,0)
 ;;=3^Primary Angle-Closure w/o Glaucoma Damage,Left Eye
 ;;^UTILITY(U,$J,358.3,8847,1,4,0)
 ;;=4^H40.062
 ;;^UTILITY(U,$J,358.3,8847,2)
 ;;=^5005745
 ;;^UTILITY(U,$J,358.3,8848,0)
 ;;=H40.10X0^^41^469^81
 ;;^UTILITY(U,$J,358.3,8848,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8848,1,3,0)
 ;;=3^Open-Angle Glaucoma,Stage Unspec
 ;;^UTILITY(U,$J,358.3,8848,1,4,0)
 ;;=4^H40.10X0
 ;;^UTILITY(U,$J,358.3,8848,2)
 ;;=^5005748
 ;;^UTILITY(U,$J,358.3,8849,0)
 ;;=H40.10X1^^41^469^78
 ;;^UTILITY(U,$J,358.3,8849,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8849,1,3,0)
 ;;=3^Open-Angle Glaucoma,Mild Stage
 ;;^UTILITY(U,$J,358.3,8849,1,4,0)
 ;;=4^H40.10X1
 ;;^UTILITY(U,$J,358.3,8849,2)
 ;;=^5005749
